Tag: Alzheimer’s disease
Medicare evaluating coverage for $56,000 Alzheimer’s drug
WASHINGTON — Medicare on Monday launched a formal process to decide whether to cover Aduhelm, the new Alzheimer's drug whose $56,000-a-year price tag and...
FDA head calls for probe into Alzheimer’s drug review
WASHINGTON — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between some...
FDA trims use of contentious Alzheimer’s drug amid backlash
WASHINGTON — U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug.
...
Does new Alzheimer’s drug work? Answers may miss 2030 target
WASHINGTON — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take...
Alzheimer’s drug stirs hope for patients, worry for doctors
In the weeks since a new Alzheimer's drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and emails about a treatment...
Lilly to seek FDA approval for potential Alzheimer’s drug
INDIANAPOLIS — Eli Lilly said Thursday that it will submit its potential Alzheimer’s treatment to federal regulators later this year.
...
EXPLAINER: How will insurers cover a new Alzheimer’s drug?
Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle...
